A Plea for the Use of Video-recorded Cystoscopy for Blinded Independent Central Review of Tumor Response in Open-label Non-muscle invasive Bladder Cancer Trials

Eur Urol Oncol. 2023 Oct;6(5):453-455. doi: 10.1016/j.euo.2023.07.005. Epub 2023 Aug 19.

Abstract

Given that most of non-muscle invasive bladder cancer trials available in the literature share the same limitation of an open-label design, they are likely prone to detection bias. Indeed, tumor response is currently assessed by unblinded investigators, mainly via follow-up cystoscopy, which has well-known intraobserver and interobserver variability. Thus, we believe that the use of video-recorded cystoscopy for blinded independent central review of tumor response could help to minimize detection bias in open-label NMIBC trials.

Publication types

  • Editorial

MeSH terms

  • Clinical Trials as Topic
  • Cystoscopy* / methods
  • Humans
  • Neoplasm Invasiveness
  • Non-Muscle Invasive Bladder Neoplasms
  • Observer Variation
  • Urinary Bladder Neoplasms* / diagnosis
  • Urinary Bladder Neoplasms* / pathology
  • Video Recording*